Skip to content

EBIT at other companies

Emergent Biosolutions logo
Emergent BiosolutionsEBS
$10.5M-79.0%
Opko Health logo
Opko HealthOPK
-$51.02M+24.0%
Stoke Therapeutics, Inc. logo
Stoke Therapeutics, Inc.STOK
-$53.42M-148%
Septerna, Inc. logo
Septerna, Inc.SEPN
-$13.3M+48.7%
Apogee Therapeutics, Inc. logo
Apogee Therapeutics, Inc.APGE
-$82.77M-31.2%
Merck & Co. logo
Merck & Co.MRK

Other financials

Income statement

See full
Revenue$6.2M-11.3%
Gross profit$3.3M-52.0%
Operating income-$5.3M-136%
Net income-$3.5M-746%
EPS (diluted)-$0.05-400%

Balance sheet

See full
Cash & equivalents$145.6M-10.3%
Total debt$601.0K-50.6%
Total equity$151.6M-29.8%
Total assets$219.4M-11.2%

Cash flow

See full
Operating cash flow-$8.7M-223%
CapEx--100%
Free cash flow-$8.7M-223%

Valuation

See full
Market cap$261.08M-44.3%
Enterprise value$116.11M-59.6%
P/E10.3×+3.8×
P/S2.8×+0.2×

Profitability

See full
Gross margin65.4%-11.2pp
Operating margin52.4%-7.8pp
Net margin43.2%-6.1pp
FCF margin66.2%

Returns & leverage

See full
Return on equity39.9%-18.5pp
Debt / equity0.0×
Current ratio3.2×-5.2×

Where this comes from

Calculated from SIGA Technologies’s reported figures.

Plus components not separately reported this period.

The official record: SIGA Technologies’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →

Ask your AI about SIGA Technologies's ebit.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is SIGA Technologies's EBIT?
SIGA Technologies (SIGA) reported EBIT of -$5.32M in Q1 2026.
How has SIGA Technologies's EBIT changed year-over-year?
SIGA Technologies's EBIT decreased by 135.9% year-over-year, from -$2.26M to -$5.32M.
What is the long-term trend for SIGA Technologies's EBIT?
Over 3 years (2021 to 2024), SIGA Technologies's EBIT has grown at a -7.7% compound annual growth rate (CAGR), from $89.09M to $69.98M.
What does EBIT mean?
Earnings before interest and taxes — the profit from the business before financing cost and tax. Uses reported operating income where a company reports it; otherwise pre-tax income plus interest expense. Lets companies be compared on earning power independent of capital structure.